Intra-Arterial Therapy for Acute Ischemic Stroke: a Golden Age

Current Treatment Options in Neurology

Volumn 17, Issue 7, 2015, Pages

  Cougo Pinto, Pedro Telles ^a,d   Chandra, Ronil V ^b   Simonsen, Claus Z ^c   Hirsch, Joshua A ^a   Leslie Mazwi, Thabele ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SOUTHERN HEALTH   (Australia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute stroke; Angiography; Endovascular therapy; Intra arterial therapy; Ischemic stroke; Large vessel occlusion; Proximal occlusion; Recanalization; Reperfusion; Treatment

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

A DIRECT ASPIRATION FIRST PASS TECHNIQUE; AMBULANCE; ARTIFICIAL EMBOLISM; ASPIRATION; ASPIRATION CATHETER; BALLOON CATHETER; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID ARTERIOGRAPHY; CAROTID ARTERY; CAROTID ARTERY FLOW; CATHETERIZATION; CLINICAL DECISION MAKING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUS SEDATION; DIFFUSION WEIGHTED IMAGING; EFFECT SIZE; EMERGENCY CARE; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; GENERAL ANESTHESIA; GUIDING CATHETER; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; IMAGING SOFTWARE; INTENSIVE CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MECHANICAL THROMBECTOMY; MICROCATHETER; MULTICENTER STUDY (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; RECANALIZATION; REHABILITATION CARE; REPERFUSION; REVIEW; SEDATION; SENSITIVITY AND SPECIFICITY; STENT RETRIEVER; STROKE PATIENT; TELEMEDICINE; THROMBECTOMY DEVICE; THROMBUS ASPIRATION; TREATMENT OUTCOME; VASCULAR ACCESS; VERTEBRAL ARTERY;

EID: 84929416012     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-015-0360-7     Document Type: Review

References (78)

1. Lima FO, Furie KL, Silva GS, Lev MH, Camargo ECS, Singhal AB, et al. Prognosis of untreated strokes due to anterior circulation proximal intracranial arterial occlusions detected by use of computed tomography angiography. JAMA Neurol. 2014;71(2):151–7.
2. Berkhemer OA, Fransen PSS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2014;372(1):11–20. These five contemporary trials (references 2-6) comparing intra-arterial therapy to best medical care represent a landmark in acute stroke care. They converge in some critical aspects: the high recanalization rates, the careful selection of eligible patients, the emphasis on early intervention, and the remarkably high effect size of benefit.
3. Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009–18. The EXTEND-IA was the smallest of the recent trials and showed benefit of IAT using a perfusion based selection paradigm.
4. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–30. The ESCAPE trial was characterized by using collateral assessment to aid the selection of eligible patients and by the emphasis on shortening times from admission to reperfusion in enrolling sites.
5. Saver JL, Goyal M, Bonafe A, Diener H-C, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015. doi:10.1056/NEJMoa1415061. SWIFT-PRIME used penumbral mismatch for the first 71 patients enrolled, and then a “small core” criterion for eligibility. Only patients who had received IV TPA were eligible. SWIFT PRIME presented the highest reperfusion rate of these positive trials.
6. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015. doi:10.1056/NEJMoa1503780. REVASCAT also used a simple small core neuroimaging criterion for including patients, and had a 8 hour window of eligibility.
7. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981;773–82.
8. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke. 1981;12(6):723–5.
9. Del Zoppo GJ, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke. 1988;19(3):307–13.
10. Nenci GG, Gresele P, Taramelli M, Agnelli G, Signorini E. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology. 1983;34(9):561–71.
11. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29(1):4–11.
12. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003–11.
13. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39(4):1205–12.
14. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36(7):1432–8.
15. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893–903. The IMS III trial (together with MR RESCUE and SYNTHESIS, following marked references), provided lessons that proved to be fundamental for the design of the contemporary, positive trials. In the IMS III trial, the lack of proof of a target vessel occlusion at baseline and the low reperfusion rates were critical for its negative outcome.
16. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914–23. MR RESCUE combined the purposes of testing IAT for patients with proximal occlusions and whether neuroimaging could help define likelihood to benefit from IAT. Reperfusion rates were unsatisfactory and time to reperfusion was relatively late.
17. Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014;273(1):202–10.
18. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(10):904–13. The SYNTHESIS trial tested IAT alone versus IV TPA. Reperfusion rates were nor reported.
19. Nogueira RG, Gupta R, Davalos A. IMS-III and SYNTHESIS expansion trials of endovascular therapy in acute ischemic stroke: how can we improve? Stroke. 2013;44(11):3272–4. A thorough critical reappraisal of the negative trials in intra-arterial therapy.
20. Goyal M, Almekhlafi MA, Fan L, Menon BK, Demchuk AM, Yeatts SD, et al. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation. 2014;130(3):265–72. This work detailed the impact of treatment delay in the IMS III trial, one of the major lessons from this negative trial.
21. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241–9. The SWIFT and TREVO (next reference) trials established the use of retrievable stents as the state of the art for reperfusion of large vessel occlusion in stroke by comparing reperfusion rates and clinical outcomes in a head-to-head comparison of the stent retrievers versus the Merci device. Here, the complete reperfusion rate achieved with the Solitaire device was 61 %, versus 24 % with Merci.
22. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380(9849):1231–40. In TEVO, a trial with similar design as SWIFT, the Trevo device yielded a reperfusion rate of 85 %, versus 60 % with Merci.
23. Kleindorfer D, Khoury J, Broderick JP, Rademacher E, Woo D, Flaherty ML, et al. Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke. 2009;40(7):2502–6.
24. Saver JL. Endovascular recanalization in acute ischemic stroke: regionalized organization of care. Neurology. 2012;79(13 Suppl 1):S3–4.
25. Nazliel B, Starkman S, Liebeskind DS, Ovbiagele B, Kim D, Sanossian N, et al. A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke. 2008;39(8):2264–7.
26. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36(7):1597–616.
27. Prabhakaran S, Ward E, John S, Lopes DK, Chen M, Temes RE, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke. 2011;42(6):1626–30.
28. Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014;311(16):1622–31.
29. Gupta R, Xiang B, Ge S, Sun C-HJ, Yoo AJ, Mehta BP. Stagnation of treatment times over a decade: results of a pooled analysis from the MERCI registry, MERCI, TREVO, and TREVO 2 trials. J Neurointerv Surg. 2015. doi:10.1136/neurintsurg-2014-011626.
30. Leifer D, Bravata DM, Connors JJB, Hinchey JA, Jauch EC, Johnston SC, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke A. Stroke. 2011;42(3):849–77.
31. Miley JT, Memon MZ, Hussein HM, Valenta DA, Suri MFK, Vazquez G, et al. A multicenter analysis of “time to microcatheter” for endovascular therapy in acute ischemic stroke. J Neuroimaging. 2011;21(2):159–64.
32. Eesa M, Menon BK, Hill MD, Demchuk A, Goyal M. Achieving faster recanalization times by IA thrombolysis in acute ischemic stroke: where should we direct our efforts? Interv Neuroradiol. 2011;17(2):228–34.
33. Yoo AJ, Leslie-Mazwi TM, Jovin TG. Future directions in IAT: better studies, better selection, better timing and better techniques. J Neurointerv Surg. 2013;5 Suppl 1:i1–6.
34. Mehta B, Leslie-Mazwi TM, Chandra RV, Chaudhry ZA, Rabinov JD, Hirsch JA, et al. Assessing variability in neurointerventional practice patterns for acute ischemic stroke. J Neurointerv Surg. 2013;5 Suppl 1:i52–7.
35. Yoo AJ, Chaudhry ZA, Leslie-Mazwi TM, Chandra RV, Hirsch JA, González RG, et al. Endovascular treatment of acute ischemic stroke: current indications. Tech Vasc Interv Radiol. 2012;15(1):33–40.
36. Yoo AJ, Chaudhry ZA, Nogueira RG, Lev MH, Schaefer PW, Schwamm LH, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke. 2012;43(5):1323–30.
37. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke. 2009;40(6):2046–54.
38. Yoo AJ, Zaidat OO, Chaudhry ZA, Berkhemer OA, González RG, Goyal M, et al. Impact of pretreatment noncontrast CT Alberta Stroke Program Early CT Score on clinical outcome after intra-arterial stroke therapy. Stroke. 2014;45(3):746–51.
39. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73(13):1066–72.
40. Souza LCS, Yoo AJ, Chaudhry ZA, Payabvash S, Kemmling A, Schaefer PW, et al. Malignant CTA collateral profile is highly specific for large admission DWI infarct core and poor outcome in acute stroke. AJNR Am J Neuroradiol. 2012;33(7):1331–6.
41. González RG, Hakimelahi R, Schaefer PW, Roccatagliata L, Sorensen AG, Singhal AB. Stability of large diffusion/perfusion mismatch in anterior circulation strokes for 4 or more hours. BMC Neurol. 2010;10:13.
42. Copen WA, Rezai Gharai L, Barak ER, Schwamm LH, Wu O, Kamalian S, et al. Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. Radiology. 2009;250(3):878–86.
43. Al-Ali F, Tomsick TA, Connors JJ, Gebel JM, Elias JJ, Markarian GZ, et al. Capillary Index Score in the Interventional Management of Stroke trials I and II. Stroke. 2014;45(7):1999–2003.
44. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke. 2010;41(9):1996–2000.
45. Ma H, Wright P, Allport L, Phan TG, Churilov L, Ly J, et al. Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome. Int J Stroke. 2014. doi:10.1111/ijs.12203.
46. Gupta AC, Schaefer PW, Chaudhry ZA, Leslie-Mazwi TM, Chandra RV, González RG, et al. Interobserver reliability of baseline noncontrast CT Alberta Stroke Program Early CT Score for intra-arterial stroke treatment selection. AJNR Am J Neuroradiol. 2012;33(6):1046–9.
47. Kamalian S, Kamalian S, Maas MB, Goldmacher GV, Payabvash S, Akbar A, et al. CT cerebral blood flow maps optimally correlate with admission diffusion-weighted imaging in acute stroke but thresholds vary by postprocessing platform. Stroke. 2011;42(7):1923–8.
48. Fiorella D, Heiserman J, Prenger E, Partovi S. Assessment of the reproducibility of postprocessing dynamic CT perfusion data. AJNR Am J Neuroradiol. 2004;25(1):97–107.
49. Campbell BCV, Yassi N, Ma H, Sharma G, Salinas S, Churilov L, et al. Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis. Int J Stroke. 2015;10(1):51–4.
50. González RG, Copen WA, Schaefer PW, Lev MH, Pomerantz SR, Rapalino O, et al. The Massachusetts General Hospital acute stroke imaging algorithm: an experience and evidence based approach. J Neurointerv Surg. 2013;5 Suppl 1:i7–12.
51. Wisco D, Uchino K, Saqqur M, Gebel JM, Aoki J, Alam S, et al. Addition of hyperacute MRI AIDS in patient selection, decreasing the use of endovascular stroke therapy. Stroke. 2014;45(2):467–72.
52. Vergouwen MDI, Algra A, Pfefferkorn T, Weimar C, Rueckert CM, Thijs V, et al. Time is brain(stem) in basilar artery occlusion. Stroke. 2012;43(11):3003–6.
53. Pallesen L-P, Gerber J, Dzialowski I, van der Hoeven EJRJ, Michel P, Pfefferkorn T, et al. Diagnostic and prognostic impact of pc-ASPECTS applied to perfusion CT in the Basilar Artery International Cooperation Study. J Neuroimaging. 2014. doi:10.1111/jon.12130.
54. Schonewille WJ, Wijman CAC, Michel P, Rueckert CM, Weimar C, Mattle HP, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8(8):724–30.
55. Rohan V, Baxa J, Tupy R, Cerna L, Sevcik P, Friesl M, et al. Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke. Stroke. 2014;45(7):2010–7.
56. Abou-Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010;41(6):1175–9.
57. Jumaa MA, Zhang F, Ruiz-Ares G, Gelzinis T, Malik AM, Aleu A, et al. Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke. 2010;41(6):1180–4.
58. Berkhemer OA. Impact of general anaesthesia on treatment effect in the MR CLEAN Trial. Oral presentation at the International Stroke Conference, Nashville, TN, 2015. Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_471851.pdf
59. Ribo M, Flores A, Rubiera M, Pagola J, Mendonca N, Rodriguez-Luna D, et al. Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome. J Neurointerv Surg. 2013;5 Suppl 1:i70–3.
60. Théron J, Guimaraens L, Casasco A, Sola T, Saleme S, Courtheoux P, et al. Radial approach in the treatment of supraaortic arterial lesions. Interv Neuroradiol. 2007;13(2):133–44.
61. Nii K, Kazekawa K, Onizuka M, Aikawa H, Tsutsumi M, Tomokiyo M, et al. Direct carotid puncture for the endovascular treatment of anterior circulation aneurysms. AJNR Am J Neuroradiol. 2006;27(7):1502–4.
62. Jadhav AP, Ribo M, Grandhi R, Linares G, Aghaebrahim A, Jovin TG, et al. Transcervical access in acute ischemic stroke. J Neurointerv Surg. 2014;6(9):652–7.
63. Chueh J-Y, Kühn AL, Puri AS, Wilson SD, Wakhloo AK, Gounis MJ. Reduction in distal emboli with proximal flow control during mechanical thrombectomy: a quantitative in vitro study. Stroke. 2013;44(5):1396–401.
64. Spiotta AM, Chaudry MI, Hui FK, Turner RD, Kellogg RT, Turk AS. Evolution of thrombectomy approaches and devices for acute stroke: a technical review. J Neurointerv Surg. 2015;7(1):2–7.
65. Turk AS, Frei D, Fiorella D, Mocco J, Baxter B, Siddiqui A, et al. ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg. 2014;6(4):260–4.
66. Kowoll A, Weber A, Mpotsaris A, Behme D, Weber W. Direct aspiration first pass technique for the treatment of acute ischemic stroke: initial experience at a European stroke center. J Neurointerv Surg. 2015. doi:10.1136/neurintsurg-2014-011520.
67. Soize S, Kadziolka K, Estrade L, Serre I, Barbe C, Pierot L. Outcome after mechanical thrombectomy using a stent retriever under conscious sedation: comparison between tandem and single occlusion of the anterior circulation. J Neuroradiol. 2014;41(2):136–42.
68. Spiotta AM, Lena J, Vargas J, Hawk H, Turner RD, Chaudry MI, et al. Proximal to distal approach in the treatment of tandem occlusions causing an acute stroke. J Neurointerv Surg. 2015;7(3):164–9.
69. Cohen JE, Gomori JM, Rajz G, Itshayek E, Eichel R, Leker RR. Extracranial carotid artery stenting followed by intracranial stent-based thrombectomy for acute tandem occlusive disease. J Neurointerv Surg. 2014. doi:10.1136/neurintsurg-2014-011175.
70. Kappelhof M, Marquering HA, Berkhemer OA, Majoie CBLM. Intra-arterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion: a literature review. J Neurointerv Surg. 2015;7(1):8–15.
71. Lockau H, Liebig T, Henning T, Neuschmelting V, Stetefeld H, Kabbasch C, et al. Mechanical thrombectomy in tandem occlusion: procedural considerations and clinical results. Neuroradiology. 2014. doi:10.1007/s00234-014-1465-5.
72. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650–63.
73. Yoo AJ, Simonsen CZ, Prabhakaran S, Chaudhry ZA, Issa MA, Fugate JE, et al. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke. 2013;44(9):2509–12.
74. Suh SH, Cloft HJ, Fugate JE, Rabinstein AA, Liebeskind DS, Kallmes DF. Clarifying differences among thrombolysis in cerebral infarction scale variants: is the artery half open or half closed? Stroke. 2013;44(4):1166–8.
75. Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke. 2005;36(2):264–8.
76. Stroke Unit Trialists Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke. 1997;28(11):2139–44.
77. Belagaje SR, Zander K, Thackeray L, Gupta R. Disposition to home or acute rehabilitation is associated with a favorable clinical outcome in the SENTIS trial. J Neurointerv Surg. 2015;7(5):322–5.
78. Belagaje SR, Sun C-HJ, Nogueira RG, Glenn BA, Wuermser LA, Patel V, et al. Discharge disposition to skilled nursing facility after endovascular reperfusion therapy predicts a poor prognosis. J Neurointerv Surg. 2015;7(2):99–103.